Dare Bioscience, INC. (DARE) — 10-Q Filings
All 10-Q filings from Dare Bioscience, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Dare Bioscience Shifts Strategy Amidst Widening Losses, Boosts Cash Reserves
— Nov 13, 2025 Risk: high
Dare Bioscience, Inc. reported a net loss of $3.56 million for the three months ended September 30, 2025, a decrease from the $4.70 million net loss in the same -
Dare Bioscience's Q2 Loss Widens Amid Strategy Shift, Cash Drains
— Aug 14, 2025 Risk: high
Dare Bioscience, Inc. reported a significant net loss of $8,394,790 for the six months ended June 30, 2025, a stark contrast to the net income of $6,155,300 rep -
Dare Bioscience Files Q1 2025 10-Q
— May 13, 2025 Risk: medium
Dare Bioscience, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Cerulean Pharma Inc. and Tempo Pharmaceuti -
Dare Bioscience Files Q3 2024 10-Q
— Nov 14, 2024 Risk: medium
Dare Bioscience, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Cerulean Pharma Inc. and Tempo Pharmaceuticals Inc -
Dare Bioscience Files Q2 2024 10-Q Report
— Aug 12, 2024 Risk: medium
Dare Bioscience, Inc. filed its quarterly report for the period ended June 30, 2024. The company is incorporated in Delaware and its principal executive offices - 10-Q Filing — May 14, 2024
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX